Switch to:
Alexion Pharmaceuticals Inc (NAS:ALXN)
EV/EBIT
59.58 (As of Today)

EV/EBIT ratio is calculated as enterprise value divided by its Earnings Before Interest and Taxes (EBIT). As of today, Alexion Pharmaceuticals Inc's enterprise value is $36,091 Mil. Alexion Pharmaceuticals Inc's earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2016 was $606 Mil. Therefore, Alexion Pharmaceuticals Inc's EV/EBIT ratio for today is 59.58.

ALXN' s EV/EBIT Range Over the Past 10 Years
Min: -115.8   Max: 499.4
Current: 59.58

-115.8
499.4

During the past 13 years, the highest EV/EBIT Ratio of Alexion Pharmaceuticals Inc was 499.40. The lowest was -115.80. And the median was 45.90.

ALXN's EV/EBIT is ranked lower than
79% of the 257 Companies
in the Global Biotechnology industry.

( Industry Median: 24.11 vs. ALXN: 59.58 )

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt). Alexion Pharmaceuticals Inc's enterprise value for the quarter that ended in Mar. 2016 was $33,758 Mil. Alexion Pharmaceuticals Inc's earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2016 was $606 Mil. Alexion Pharmaceuticals Inc's Earnings Yield (Joel Greenblatt) for the quarter that ended in Mar. 2016 was 1.79%.


Definition

Alexion Pharmaceuticals Inc's EV/EBIT for today is calculated as:

EV/EBIT=Enterprise Value (Today)/Earnings Before Interest and Taxes (EBIT) (TTM)
=36090.661/605.778
=59.58

Alexion Pharmaceuticals Inc's current Enterprise Value is $36,091 Mil.
Alexion Pharmaceuticals Inc's Earnings Before Interest and Taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2016 was 181.263 (Jun. 2015 ) + 159.33 (Sep. 2015 ) + 97.697 (Dec. 2015 ) + 167.488 (Mar. 2016 ) = $606 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

This is a more accurate valuation of companies' operation because it consider the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt).

Alexion Pharmaceuticals Inc's Earnings Yield (Joel Greenblatt) for the quarter that ended in Mar. 2016 is calculated as:

Earnings Yield (Joel Greenblatt) (Q: Mar. 2016 )=EBIT (TTM)/Enterprise Value (Q: Mar. 2016 )
=605.778/33758.4218
=1.79 %

Alexion Pharmaceuticals Inc's Enterprise Value for the quarter that ended in Mar. 2016 was $33,758 Mil.
Alexion Pharmaceuticals Inc's Earnings Before Interest and Taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2016 was 181.263 (Jun. 2015 ) + 159.33 (Sep. 2015 ) + 97.697 (Dec. 2015 ) + 167.488 (Mar. 2016 ) = $606 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Related Terms

Enterprise Value, Earnings Yield (Joel Greenblatt), Earnings Before Interest and Taxes (EBIT)


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Alexion Pharmaceuticals Inc Annual Data

Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
ev2ebit -10.81-32.3276.1349.8046.8555.2142.9946.7640.0482.92

Alexion Pharmaceuticals Inc Quarterly Data

Dec13Mar14Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16
ev2ebit 46.7645.9341.7138.6940.0442.6658.7257.3882.9255.73
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK